274 related articles for article (PubMed ID: 8544526)
1. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
Wallin A
Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
[No Abstract] [Full Text] [Related]
2. [Tacrine].
Dávila C; Viteri C; de Castro P
Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic results: tacrine].
Ventura M; Sternon J
Rev Med Brux; 1997 Dec; 18(6):394-7. PubMed ID: 9481161
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to tacrine, arterial hypotension and leuko-araiosis in Alzheimer's disease.
Lebert F; Mouly C; Pasquier F
Age Ageing; 1998 Sep; 27(5):654. PubMed ID: 12675108
[No Abstract] [Full Text] [Related]
5. Treatment for Alzheimer's disease.
Wilcock GK
Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
[No Abstract] [Full Text] [Related]
6. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease].
García-Díaz JD; Fraguas C; Garcimartín C
Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247
[No Abstract] [Full Text] [Related]
7. Advances in the treatment of Alzheimer's disease.
Schneider LS
Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
[No Abstract] [Full Text] [Related]
8. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
Masterman D
Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
[No Abstract] [Full Text] [Related]
9. Cognition-enhancing drugs in dementia: a guide to the near future.
van Reekum R; Black SE; Conn D; Clarke D
Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: the role of tacrine therapy.
Jogerst G
Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
[No Abstract] [Full Text] [Related]
11. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
[No Abstract] [Full Text] [Related]
12. [Clinical study of patients with Alzheimer's disease under treatment with tacrine].
García-López MT; Guardado-Santervás P
Rev Neurol; 2001 Feb 16-28; 32(4):394-7. PubMed ID: 11398762
[No Abstract] [Full Text] [Related]
13. Pharmacoepidemiology of tacrine in Alzheimer's disease.
Begaud B; Haramburu F; Miremont G
Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():77-8. PubMed ID: 8899701
[No Abstract] [Full Text] [Related]
14. Tacrine: a second look. An outdated drug to be discarded.
Prescrire Int; 1999 Feb; 8(39):16-8. PubMed ID: 10557569
[TBL] [Abstract][Full Text] [Related]
15. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
16. Donepezil: new preparation. Moderate efficacy in Alzheimer's disease.
Prescrire Int; 1998 Oct; 7(37):146-7. PubMed ID: 10915420
[TBL] [Abstract][Full Text] [Related]
17. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic trials using tacrine and other cholinesterase inhibitors.
Gamzu ER; Thal LJ; Davis KL
Adv Neurol; 1990; 51():241-5. PubMed ID: 2403716
[TBL] [Abstract][Full Text] [Related]
19. [Post-marketing observational study of donepezil].
Ibach B
Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
[No Abstract] [Full Text] [Related]
20. [Alzheimer's disease. Foreword].
Derquesné C
Rev Prat; 1998 Nov; 48(17):1871-2. PubMed ID: 9882238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
